The family hypercholesterolemia
- 作者: Pshennova V.S.1
-
隶属关系:
- The N.I. Pirogov Russian national research medical university
- 期: 卷 22, 编号 5 (2016)
- 页面: 272-276
- 栏目: Articles
- URL: https://journal-vniispk.ru/0869-2106/article/view/38359
- DOI: https://doi.org/10.18821/0869-2106-2016-22-5-272-276
- ID: 38359
如何引用文章
全文:
详细
作者简介
Veronika Pshennova
The N.I. Pirogov Russian national research medical university
Email: veronika_80@list.ru
candidate of medical sciences, assistant of the department of Internal Medicine Medicobiologic faculty The N.I. Pirogov Russian national research medical university 117997, Moscow, Russia
参考
- Goldberg A.C., Hopkins P.N., Toth P.P., Ballantyne C.M., Rader D.J., Robinson J.G. et al. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J. Clin. Lipidol. 2011; 5(3Suppl.): S1-8.
- Кухарчук В.В., Малышев П.П., Мешков А.Н. Семейная гиперхолестеринемия: современные аспекты диагностики, профилактики и терапии. Кардиология. 2009; (1): 76-83.
- Сафарова М.С., Сергиенко И.В., Ежов М.В., Семенова А.Е., Качковский М.А., Шапошник И.И. и др. Российская научно-исследовательская программа по своевременной диагностике и лечению больных семейной гиперхолестеринемией: обоснование и дизайн российского регистра семейной гиперхолестеринемии (РоСГХС). Атеросклероз и дислипидемия. 2014; (3): 7-15.
- Бочков Н.П. Клиническая генетика. М.: ГЭОТАР-Мед; 2002.
- Fahed A.C., Nemer G.M. Familial hypercholesterolemia: the lipids or the genes? Nutr. Metab. (Lond). 2011; 8(1): 23.
- Luirink I.K., Hutten B.A., Wiegman A. Optimizing Treatment of Familial Hypercholesterolemia in Children and Adolescents. Curr. Cardiol. Rep. 2015; 17(9): 629.
- Daniels S.R. Familial Hypercholesterolemia: The Reason to Screen Children for Cholesterol Abnormalities. J. Pediatr. 2016; 170: 7-8.
- Watts G.F., Gidding S., Wierzbicki A.S., Toth P.P., Alonso R., Brown W.V. et al. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation. Int. J. Cardiol. 2014; 171(3): 309-25.
- European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z., Catapano A.L., De Backer G., Graham I., Taskinen M.R. et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur. Heart J. 2011; 32(14): 1769-818.
- Patel R.S., Scopelliti E.M., Savelloni J. Therapeutic Management of Familial Hypercholesterolemia: Current and Emerging Drug Therapies. Pharmacotherapy. 2015; 35(12): 1189-203.
- Сусеков А.В. Эзетимиб, ингибитор адсорбции холестерина: новые возможности в лечении дислипидемий и атеросклероза. Терапевтический архив. 2005; 77(8): 24-9.
- Seidah N.G. Proprotein convertase subtilisin kexin 9 (PCSK9) inhibitors in the treatment of hypercholesterolemia and other pathologies. Curr. Pharm. Des. 2013; 19(17): 3161-72.
- Visser M.E., Witztum J.L., Stroes E.S., Kastelein J.J. Antisense oligonucleotides for the treatment of dyslipidaemia. Eur. Heart J. 2012; 33: 1451-8.
- Cuchel M., Rader D.J. Microsomal transfer protein inhibition in humans. Curr. Opin. Lipidol. 2013; 24: 246-50.
补充文件
